- The US medical technology firm has lined up
Xtant Medical Holdings as a stalking horse bidder - Meanwhile, Prompt Protypes is lined up as a buyer for Surgalign Spine Technologies
- Equity interests of the company’s non-US hardware subsidiaries that aren’t sold or part of sale agreements could be dissolved
- As part of a
restructuring plan, the company has been removing underperforming products from its portfolio and cut roughly 20% of its employee count ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.